This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Research Highlights: A preliminary study combining a patent-applied, AI-powered algorithm with a high-speed, 5-to 30-second video of skin on the face and the palm of the hand detected if someone had high bloodpressure as well as using a blood.
Young adults who reported higher stress as adolescents were more likely to have high bloodpressure, obesity and other cardiometabolic risk factors as adults, finds new study.
In this trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-pressure target of less than 120 mm Hg than with a target of less than 140 mm Hg.
Tirzepatide, a dual GLP-1/GIP agonist approved for diabetes and obesity, was associated with significant bloodpressure reductions in an analysis of the SURMOUNT-1 trial.
Reducing systolic bloodpressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
(MedPage Today) -- CHICAGO -- The cardiovascular outcome benefit of a tighter systolic bloodpressure target was affirmed in patients with type 2 diabetes in the randomized BPROAD trial from China. A target of less than 120 mm Hg reduced a composite.
The risk of hypertension increased with the presence of associated CV risk factors and comorbidities, particularly diabetes, obesity and the metabolic syndrome, and decreased with the intensity of physical activity. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 Regarding antihypertensive treatments, 6.1% two drugs, and 19.6%
Researchers studied oxygen treatment as a potential therapy to target specific cells linked to the development of cardiovascular and metabolic disorders like high bloodpressure and type 2 diabetes and found no significant improvement in function in patients with type 2 diabetes.
Research Highlights: Consistently high scores of perceived stress during adolescence through adulthood may contribute to worse cardiometabolic health including obesity in young adults. Researchers suggest the adoption of healthy coping strategies.
Young adults who reported higher stress during their teenage years to adulthood were more likely to have high bloodpressure, obesity and other cardiometabolic risk factors than their peers who reported less stress, according to new research published in the Journal of the American Heart Association.
E.g. High BloodPressure, Diabetes Diagnosed three years ago. BloodPressure I think that bloodpressure taken in clinical settings is as close to useless as makes no difference. Taking bloodpressure in a doctor’s office is mostly theatre. That is your bloodpressure.
The Defining Risk module includes lessons on: Defining Metabolic Health Cholesterol Principles Understanding Your Cholesterol Panel Advanced Cholesterol Testing Lipoprotein (a) - Lp(a) Insulin Resistance Metabolic Syndrome Pre-Diabetes & Diabetes Assessing Visceral Fat How To Measure Fitness The Importance of Muscle Metrics.
Elevated bloodpressure mediates much of the organ toxicity affecting persons with type 2 diabetes. The management of hypertension occupies as much clinical attention as that of dysglycemia, yet the recommended blood-pressure target in type 2 diabetes remains controversial.
The goal of the BPROAD trial was to determine the efficacy and safety of an intensive bloodpressure (BP)-lowering strategy in patients with type 2 diabetes mellitus (T2DM) and hypertension with respect to future cardiovascular disease (CVD) events.
Research Highlights: A study of almost 13,000 adults with Type 2 diabetes and high systolic bloodpressure assessed if a more intensive treatment approach with a lower bloodpressure goal would decrease the risk of major cardiovascular events,
The Defining Risk module includes lessons on: Defining Metabolic Health Cholesterol Principles Understanding Your Cholesterol Panel Advanced Cholesterol Testing Lipoprotein (a) - Lp(a) Insulin Resistance Metabolic Syndrome Pre-Diabetes & Diabetes Assessing Visceral Fat How To Measure Fitness The Importance of Muscle Metrics.
As of now, there are no data to support its use as a treatment for diabetic cardiomyopathy (DCM) and the mechanism behind the effect is unclear as well. ZGCD not only significantly reduces bloodpressure, but also enhances cardiac function while producing fewer adverse effects.
Hot tubs can improve insulin effectiveness, heart health and lower bloodpressure in people with type 2 diabetes, research from the University of Portsmouth has found.
The frequent concurrence of elevated bloodpressure (BP) and type 2 diabetes markedly elevates the risk of cardiovascular disease and mortality. The review introduces a mediation model, delineating the intricate interplay between hypertension and diabetes and their joint contribution to cardiovascular and renal pathologies.
BACKGROUND:The optimal approach to implementing telemedicine hypertension management in the United States is unknown.METHODS:We examined telemedicine hypertension management versus the effect of usual clinic-based care on bloodpressure (BP) and patient/clinician-related heterogeneity in a systematic review/meta-analysis.
We evaluated the prevalence of “heart stress” (HS) based on NT-proBNP cut-points proposed by the 2023 Consensus of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in asymptomati.
A study has found cardiovascular conditions such as high bloodpressure and diabetes, which are known to contribute to brain blood vessel damage in younger populations, not to be associated with an increased risk of such harm in individuals 90 and older.
If current guidelines for cholesterol and high bloodpressure treatment remain unchanged, a newly unveiled heart risk calculator would render 16 million people ineligible for preventive therapy.
Research Highlights: Heart disease, Type 2 diabetes, high bloodpressure and obesity were more common and linked to reduced access to healthy food among people who lived in neighborhoods previously subjected to structural racism-based policies that.
The risk prediction equation focused on diabetes control and kidney damage indicates that smoking, Type 2 diabetes, high bloodpressure, previous heart attack and diabetes-related kidney damage are associated with increased risk of developing heart failure among American Indian adults.
These findings may inform efforts to prevent excessive weight gain early in life, a risk factor for adult obesity and related conditions, such as heart disease, high bloodpressure and diabetes.
In this week’s View, Dr. Eagle looks at office measurement vs. ambulatory bloodpressure monitoring and its associations with mortality in patients with or without diabetes.
A projected rise in heart disease and stroke – along with several key risk factors, including high bloodpressure and obesity – is likely to triple related costs to $1.8 According to their projections, from 2020 to 2050, high bloodpressure is expected to rise from 51.2% The diabetes rate is expected to rise from 16.3%
The relationship between ankle bloodpressure (BP) and cardiovascular disease remains unclear. We examined the relationships between known and new ankle BP indices and major cardiovascular outcomes in people w.
Intensive treatment to control systolic bloodpressure (BP) to less than 120 mmHg significantly reduced the incidence of major cardiovascular events in patients over the age of 50 with type 2 diabetes, based on results from the BPROAD trial.
to 0%) Despite these massive BP medication reductions , the gastric bypass group saw no significant difference in bloodpressure, and 54.7% The GATEWAY trial assigned 100 participants (76% women, 43.8 vs. 13.7%) Gastric bypass patients were taking far fewer different BP medications (0.8 of them achieved BPs below 130/80 mm Hg (vs.
Resistant hypertension is defined by the American Heart Association as elevated bloodpressure despite the use of three or more antihypertensive medications in different classes, including a diuretic. The Momentum trial, which will enroll 1,000 patients across 45 sites in the U.S.,
The real-world patient population analysis, which is the largest dataset of Prevail patients with nearly 1,800 patients, compared the Prevail DCB to other DCBs in a complex patient population, including bifurcations, acute coronary syndrome and diabetes. BloodPressure Response Following Radiofrequency Renal Denervation" was presented byDr.
Circadian rhythms in bloodpressure and heart rate, among other functions, are crucial for cardiovascular health and preventing cardiovascular disease. This is supported by studies showing that ALAN exposure is associated with a range of conditions like cardiometabolic disease, obesity, and diabetes.
Statement Highlights: By age 18, many adolescents have already developed heart disease risk factors, such as high bloodpressure, obesity, high cholesterol or Type 2 diabetes, and a growing number of younger adults are experiencing adverse.
The research found that heavy drinkers with either diabetes, high bloodpressure or a high waist circumference are as much as 2.4 times more likely to develop advanced liver disease.
The five classic risk factors for cardiovascular disease are well knownsmoking, high bloodpressure, high cholesterol, diabetes, and underweight or overweight/obesity. All increase the likelihood of heart ailments down the road.
It looks like we might be able to add prediabetes and hypertension to the growing list of conditions that Eli Lilly’s “weight loss drug” tirzepatide is able to treat, after new analysis of the SURMOUNT-1 trial showed significant reductions in bloodpressure and diabetes progression. mm Hg systolic and 4.2 of placebo-takers.
Patients with no history of atherosclerotic CVD started on bloodpressure and/or lipid and/or glucose lowering treatments were identified retrospectively and interviewed at least 6 months after the initiation of medication. of patients on bloodpressure-lowering therapies achieved the target of<140/90 mm Hg.
found that women with poor cardiovascular health after pregnancy or who experienced adverse pregnancy outcomes, including high bloodpressure, gestational diabetes. Research Highlights: An analysis of health records for almost 110,000 women in the U.K.
BACKGROUNDElevated bloodpressure (BP) is associated with increased risk of cardiovascular mortality. However, there is ongoing debate whether intensive BP lowering may paradoxically increase the risk of cardiovascular disease (CVD), especially in patients with type 2 diabetes (T2D).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content